Racemic ketamine treatment attenuates anterior cingulate cortex GABA deficits among remitters in treatment-resistant depression: A pilot study

Psychiatry Res Neuroimaging. 2022 Mar:320:111432. doi: 10.1016/j.pscychresns.2021.111432. Epub 2021 Dec 24.
No abstract available

Publication types

  • Letter

MeSH terms

  • Depression
  • Gyrus Cinguli / diagnostic imaging
  • Humans
  • Ketamine* / pharmacology
  • Ketamine* / therapeutic use
  • Pilot Projects
  • gamma-Aminobutyric Acid / therapeutic use

Substances

  • gamma-Aminobutyric Acid
  • Ketamine

Associated data

  • ClinicalTrials.gov/NCT03573349